Journal
EXPERT REVIEW OF CLINICAL IMMUNOLOGY
Volume 11, Issue 4, Pages 479-488Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/1744666X.2015.1019475
Keywords
angiogenesis; Crohn's disease; factor V Leiden; homocysteine; ulcerative colitis; venous thromboembolism
Categories
Ask authors/readers for more resources
Inflammatory bowel disease (IBD) is associated with a hypercoagulable state and subsequently with an increased risk for venous thromboembolism (VTE). VTE in IBD is characterized by a high recurrence rate and is associated with the disease activity. Acquired endothelial dysfunction, abnormalities of platelets, activation of coagulation system and impaired fibrinolysis are the main changes in the coagulation state in IBD. The development of VTE in IBD has been considered to be the result of multiple interactions between acquired and inherited risk factors. The treatment of VTE in IBD patients is recommended to be similar and to follow the same protocols as for non-IBD patients. In the clinical practice, the management of IBD patients and especially the hospitalized patients should include thromboprophylaxis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available